Company / Operating Cash Flow per Share
Eloxx Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.56
FY2025
5-year range
-$4.56 / -$0.26
FY2021-FY2025
Trend
-1657.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -1657% YoY in FY2025, a notable deviation from the 3-year average annual change of -521%.
Based on SEC 10-K filings.
-4.56 in FY2025.
Declined from $-0.28 to $-4.56 over the past 10 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 1657.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.56 | -1657.5% |
| FY2016 | -$0.26 | +7.9% |
| FY2015 | -$0.28 | +85.4% |
| FY2014 | -$1.93 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026